Orion Corp. Class A (ORNAV)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

€  11.19
   
  • 52 Week High: € 13.70
  • 52 Week Low: € 10.50
  • Currency: Euro
  • Shares Issued: 47.56m
  • Market Cap: € 532.24m

ORNAV Overview

Orion Corporation is a 45nish company, which develops, manufactures and markets pharmaceuticals. Its products are used to treat diseases of the central nervous system, cardiology, urology, oncology and in critical care. It also provides active pharmaceutical ingredients and diagnostic tests for global markets. The Group operates in Scandinavia, Europe, North America and other countries.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover 1.1
Op Mrgn 29.9%
ROCE 51.1%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 10.2%
PBT 24.0%
EPS 22.4%
DPS 20.0%

ORNAV Fundamentals

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
01-Dec-07 683.60 195.50 103.00¢ 15.8 n/a -7% 100.00¢ 6.1%
31-Dec-07 680.00 193.40 102.00¢ 15.8 n/a -1% 100.00¢ 6.2%
31-Dec-08 710.70 184.20 97.00¢ 12.4 n/a -5% 100.00¢ 8.3%
31-Dec-09 771.50 203.70 107.00¢ 11.3 1.1 +10% 100.00¢ 8.3%
31-Dec-10 849.90 252.60 131.00¢ n/a n/a +22% 120.00¢ 0.0%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

ORNAV Market Data

Currency Euro
% Change 0.09 %
52 Week High € 13.70
52 Week Low € 10.50
Shares Issued 47.56m
Market Cap € 532.24m

Top of Page